Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure

PURPOSE: The use of sodium-glucose-cotransporter-type-2 inhibitors (SGLT2i) was associated in previous studies with an improved vascular function in non-human experimental models. We therefore sought to evaluate possible changes in endothelial function assessed by flow-mediated dilation (FMD) in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Michele, Mazzeo, Pietro, Mallardi, Adriana, Leopizzi, Alessandra, Tricarico, Lucia, Fortunato, Martino, Magnesa, Michele, Tucci, Salvatore, Maiellaro, Pasquale, Pastore, Giuseppe, Lamacchia, Olga, Iacoviello, Massimo, Di Biase, Matteo, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652233/
https://www.ncbi.nlm.nih.gov/pubmed/34519913
http://dx.doi.org/10.1007/s10557-021-07254-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652233/
https://www.ncbi.nlm.nih.gov/pubmed/34519913
http://dx.doi.org/10.1007/s10557-021-07254-3

Ejemplares similares